Genprex
GNPX
22 hedge funds and large institutions have $16.7M invested in Genprex in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 10 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
6% more capital invested
Capital invested by funds: $15.9M → $16.7M (+$895K)
2% more call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.18M
0% less ownership
Funds ownership: 0% → 0% (-0%)
24% less funds holding
Funds holding: 29 → 22 (-7)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$315K |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$315K |
| 3 |
BlackRock
New York
|
+$158K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$158K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$158K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$372K |
| 2 |
Barclays
London,
United Kingdom
|
-$315K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$270K |
| 4 |
Jane Street
New York
|
-$161K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$158K |
GNPX Hedge Fund Activity: Q3 2020 in Review
22 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2020, worth a combined $16.7M — up 5.6% from $15.9M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GNPX and 3 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was AQR Capital Management, opening a new position worth an estimated $315K. The largest seller was Sabby Management, exiting entirely with an estimated $372K sold.
- 22 institutional investors held Genprex (GNPX) as of Q3 2020, down from 29 in Q2 2020.
- Funds reported $16.7M of Genprex stock for Q3 2020, up 5.6% quarter-over-quarter.
- 3 funds opened new Genprex positions in Q3 2020 and 10 closed out, a net change of -7 holders.
- The largest Genprex buyer in Q3 2020 was AQR Capital Management, an estimated $315K added.
- The largest Genprex seller in Q3 2020 was Sabby Management, an estimated $372K sold.
Based on aggregated 13F filings for Q3 2020.